These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6508987)

  • 1. The protein binding of timegadine determined by equilibrium dialysis.
    George S; McBurney A; Ward J
    Br J Clin Pharmacol; 1984 Nov; 18(5):785-90. PubMed ID: 6508987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of timegadine and two of its metabolites after multiple oral dosing, and the effects of concomitant administration of ibuprofen.
    George S; McBurney A; Ward JW
    Eur J Clin Pharmacol; 1986; 29(5):581-6. PubMed ID: 3956563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of food intake on the bioavailability of timegadine, a novel non-steroidal anti-inflammatory drug.
    George S; Dauwe K; McBurney A; Ward J
    Br J Clin Pharmacol; 1983 Apr; 15(4):495-8. PubMed ID: 6849788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.
    David BM; Tjokrosetio R; Ilett KF
    Ther Drug Monit; 1983; 5(1):81-6. PubMed ID: 6845403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative trial of timegadine and D-penicillamine in rheumatoid arthritis.
    Mbuyi-Muamba JM; Dequeker J
    Clin Rheumatol; 1983 Dec; 2(4):369-74. PubMed ID: 6678197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding and interaction studies with piroxicam.
    Trnavská Z; Trnavský K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):81-5. PubMed ID: 6493354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
    Brunner F; Zini R; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):134-9. PubMed ID: 6201451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual profile of activity of a new basic anti-inflammatory drug, timegadine.
    Bramm E; Binderup L; Arrigoni-Martelli E
    Agents Actions; 1981 Jul; 11(4):402-9. PubMed ID: 6974455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite.
    Machinist JM; Kukulka MJ; Bopp BA
    Clin Pharmacokinet; 1995; 29 Suppl 2():34-41. PubMed ID: 8620669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog.
    Niwa T; Tokuma Y; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of volume shifts on drug binding during equilibrium dialysis: correction and attenuation.
    Lima JJ; MacKichan JJ; Libertin N; Sabino J
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):483-98. PubMed ID: 6668555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the plasma protein binding of verapamil and norverapamil in man.
    Yong CL; Kunka RL; Bates TR
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):329-39. PubMed ID: 7444161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
    Behm HL; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the protein binding of bumetanide using an equilibrium dialysis technique.
    Shim HJ; Lee MG; Lee MH
    J Clin Pharm Ther; 1991 Dec; 16(6):467-76. PubMed ID: 1770075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.
    Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Faure G; Pourel J; Martin J; Gaucher A
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):109-16. PubMed ID: 6745302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of theophylline to serum proteins of hemodialysis patients.
    Reidenberg MM; Restivo K
    J Dial; 1979; 3(4):375-81. PubMed ID: 263959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol binding to human blood proteins.
    Altmayer P; Büch U; Büch HP
    Arzneimittelforschung; 1995 Oct; 45(10):1053-6. PubMed ID: 8595056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.